Successful immunosuppressive therapy for HTLV-I associated myelopathy.
Misra
A K
AK
Neurology Service (752/127), School of Medicine, Department of Veterans Affairs Outpatient Clinic, Los Angeles, CA.
Mishra
S K
SK
Eigen
A C
AC
Tourtellotte
W W
WW
D000380:Agranulocytosis / Q000139:chemically induced; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015493:Paraparesis, Tropical Spastic / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use*
D003520:Cyclophosphamide; D011241:Prednisone